1. Rabbit bones in tissue culture synthesize an inhibitor of collagenase during the first 4 days of culture. 2. The inhibitor was purified by a combination of gel filtration, concanavalin A-Sepharose chromatography, ion-exchange chromatography and zinc-chelate affinity chromatography. 3. The purified inhibitor migrated as a single band on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis and had a mol.wt. of 28000. 4. The inhibitor blocked the activity of the metalloproteinases collagenase, gelatinase, neutral proteinase III (proteoglycanase), human leucocyte collagenase and gelatinase, but not thermolysin or bacterial collagenase. The serine proteinases plasmin and trypsin were not inhibited. 5. The inhibitor interacted with purified rabbit bone collagenase with 1: 1 stoichiometry. 6. The inhibitory activity was lost after incubation for I h at 900C, after treatment with trypsin (250,ug/ml) at 370C for 30min and after reduction and alkylation.
Connective tissues in culture synthesize metalloproteinases capable of digesting collagen and proteoglycan (Sellers et al., 1978) . Much interest has been shown in the way in which the tissues control the extracellular activity of these enzymes, to allow remodelling of the macromolecules when necessary, but to prevent irreversible breakdown of the matrix. The metalloproteinases are usually -secreted in a latent form and require activation before they can digest their substrates, and it is likely that this represents one mechanism of control. The most widely studied-latent metalloproteinase, collagenase, can be activated by trypsin and also by mercurials and chaotropic ions, and it has been proposed that latent collagenase consists of the enzyme in combination with inhibitor .
Inhibitors, of collagenase have been discovered in serum (Abe & Nagai, 1972; Werb et al., 1974; Woolley et al., 1976) , in tissue extracts (McCroskery et al., 1975; Kuettner et al., 1977; Roughley et al., 1978) , in media from connectivetissue cells in culture (Nolan et al., 1978; Welgus et al., 1979) and in the media from connective tissues Shinkai et al., 1977; Vater et al., 1979; Nolan et al., 1980) . Only the inhibitors synthesized in tissue culture, however, have been Abbreviation used: SDS, sodium dodecyl sulphate. Vol. 195 shown to combine with the enzyme to give a complex that is similar to the latent collagenase ; Vater et al., 1978) . In addition, the tissue collagenase inhibitor blocks the action of two other metalloproteinases that degrade gelatin and proteoglycan (Sellers et al., 1979) . It therefore seems likely that connective tissues produce this inhibitor to control selectively the extracellular activity of tissue metalloproteinases.
In order to determine if latent collagenase consists of enzyme in combination with this tissue inhibitor, it is necessary to purify both enzyme and inhibitor and study their interaction. In the present paper we describe a purification procedure for the isolation of the rabbit bone inhibitor of collagenase. A preliminary report of part of this work has been published (Cawston et al., 1980b Amersham, Bucks., U.K.; Coomassie Brilliant Blue G250 from Raymond A. Lamb, London NW1O 5JL, U.K.; heparin-Sepharose and the zinc-chelate column were prepared as previously described (Cawston & Tyler, 1979) .
All other chemicals and biochemicals were commercially available analytical-grade reagents or have been previously described (Cawston & Tyler, 1979; Tyler & Cawston, 1980; Cawston et al., 1980a) .
Methods
Culture techniques. The cranial vaults of newborn (1-2-day-old) rabbits were cultured in a modified form of BGJ medium (Reynolds, 1976) with no added serum. Each dish contained one bone in 5.Oml of medium and the medium was changed every day for 14 days. Collagenase inhibitor was produced during the first 3-4 days of culture , and media containing inhibitor were pooled, filtered through Whatman no. 54 filter paper and diluted 1:10 with 1 M-Tris/HCl buffer, pH 7.6, containing 100mM-CaCl2. The pooled medium was stored at -200C until required for inhibitor purification.
Enzyme assays. [ 14C lAcetylated collagen was used to measure collagenolytic activity by using the diffuse-fibril assay (Cawston & Barrett, 1979) . For collagenase-inhibitor assays, a known amount of collagenase (0.06 unit) was added and assayed in the presence of inhibitor samples. A unit of collagenase degrades 1 g of collagen/min at 370C, and 1 unit of inhibitor is defined as that giving 50% inhibition of 2 units of collagenase . Gelatindegrading activity was assayed using 14C-labelled gelatin at 370C as described by . Casein-degrading activity (proteoglycanase; Sellers et al., 1978) (Cawston & Barrett, 1979) (200,u1) of the supernatant was counted for 14C radioactivity as previously described (Cawston & Barrett, 1979) . The release of radioactivity into the supernatant was linear up to 30% lysis of casein. One unit of caseinase activity degrades lug of casein/min at 370C to peptides soluble in 3% (w/v) trichloroacetic acid.
Protein determination. Column eluates were monitored for protein by measuring A280. The protein content of samples from each stage of the purification was determined with fluorescamine as previously described (Cawston & Tyler, 1979) .
Iodination of proteins with 12sL Protein samples (80p1) with 0.1 M-sodium borate buffer, pH 8.5 (20,u1) , were added to tubes containing 50100,uCi of dried N-succinimidyl 3-(4-hydroxy-5-[ 1231-iodophenyl)propionate and agitated for 15 min at OOC.
SDS/polyacrylamide-gel electrophoresis. Protein samples were mixed with 50mM-Tris/HCl, pH6.8, containing 1% (w/v) SDS, 1% (v/v) glycerol and 0.0002% Bromophenol Blue and heated at 100°C for 5-10min. Polyacrylamide slab gels (17.4 cm x 13.6cm x 0.014cm) were poured, the lower gel containing 12.5% (w/v) total acrylamides and 2.5% (w/w) bisacrylamide and the spacer gel containing 4.5% (w/v) total acrylamides and 2.5% (w/w) bisacrylamide. Polymerization and all other procedures were as previously described (Cawston & Tyler, 1979) , and the gels were run in a Shandon (model 200) vertical polyacrylamide-slab-gel electrophoresis apparatus.
Gel slabs were fixed for 5 min in 40% (w/v) trichloroacetic acid, washed in water and stained for 30-60min in a solution of 0.25% Coomassie Brilliant Blue G250 in methanol/acetic acid/water (5:1:4, by vol.), and destained in methanol/acetic acid/water (30:1:69, by vol.). The polyacrylamide gels were photographed, dried and radioautographed as described previously (Cawston & Tyler, 1979) .
Column chromatography. All columns were run at 40C and all buffers contained 0.05% Brij 35, with NaN3 (0.02%) as a preservative.
Purification of rabbit bone collagenase. Rabbit bones were cultured for 14 days, and the daily changes of medium from day 4 onwards were combined. The pooled medium was concentrated by ultrafiltration with a Millipore Pellicon membrane (type PTGC), and purified by the method of Cawston & Tyler (1979) .
Results
Scheme 1 summarizes the purification procedure that we used for the isolation of the rabbit bone tissue inhibitor of metalloproteinases.
Concentration ofmedium
The pooled medium was thawed and concentrated either by ultrafiltration through a Millipore Pellicon PTGC membrane, or dialysed against water to remove most of the salt, freeze-dried, and then resuspended in 25 mM-sodium cacodylate buffer, pH 7.2, containing 10mM-CaCl2, 0.05% Brij 35, 1 M-NaCl and 0.02% NaN3 (column buffer).
Medium concentrated by either method was dialysed against this buffer overnight and then centrifuged at 400000g for 1 h at 40C to remove any insoluble protein.
Gel filtration on Ultrogel AcA 44. A column of Ultrogel AcA 44 was equilibrated with column buffer, and the concentrated medium was applied and eluted by reverse flow. elution profile that was obtained. The tissue inhibitor was eluted in a broad peak relatively free of the major protein and of the three latent metalloproteinases. A large peak of latent collagenase was eluted before the inhibitor. The fractions containing inhibitor were combined and MgCl2 (1 mM) and MnCl2 (ImM) added. In all, four such gel-filtration columns were run, and the fractions containing inhibitor from each were combined.
Concanavalin A-Sepharose chromatography The combined fractions from the Ultrogel AcA 44 columns were applied to a column of concanavalin A-Sepharose equilibrated with column buffer containing MgCl2 (1 mM) and MnCl2 (1 mM) and then eluted with this buffer until the absorbance of the fractions was equal to that of the buffer. The adsorbed glycoproteins were removed from the column by washing with column buffer containing 2% (w/v) 1-0-methyl a-D-glucopyranoside. A small protein peak was eluted that contained the tissue inhibitor (Fig. 2) . The fractions containing the inhibitor were pooled and concentrated by ultrafiltration with an Amicon PM 10 membrane and dialysed against 40 mM-sodium barbitone buffer containing 40mM-NaCl, 0.05% Brij 35 and 0.02% NaN3.
DEAE-Sepharose chromatography
The concentrated fractions from step 3 in the sodium barbitone buffer were loaded on to a column 50  60  70  80  90  100  110  120  130  140  150  160  170  180 Fraction no. Fig. 1 . Gelfiltration ofrabbit bone inhibitor ofcollagenase Concentrated medium (55 ml) was applied to a column (4.4cm x 115cm) of Ultrogel AcA 44 equilibrated with 25 mM-sodium cacodylate, pH 7.2, containing 1 M-NaCI, lOmM-CaCI2, 0.05% Brij 35 and 0.02% NaN3 (column buffer). The column was eluted with this buffer at a flow rate of 30 ml/h and the fractions (11.6 ml) monitored for protein (A280.
) collagenase (0) and metalloproteinases (['4Clgelatin-degrading activity, 0; [14Clcasein-degrading activity, E) and collagenase inhibitor (----). Fraction no. Fig. 3 . DEAE-Sepharose chromatography of rabbit bone inhibitor ofcollagenase Fractions containing rabbit bone inhibitor of collagenase from concanavalin A-Sepharose chromatography were concentrated by ultrafiltration and dialysed overnight against 40 mM-sodium barbitone, pH 7.6, containing 40mM-NaCl, 0.05% Brij 35, and 0.02% NaN3. The concentrated fractions (5 ml) were loaded on to a pre-equilibrated column of DEAE-Sepharose (0.9cmx28cm) and eluted at a flow rate of lOml/h with a large volume of the above buffer. Adsorbed protein was removed by washing with 1M-NaCl and the fractions (1ml) were monitored for protein (A 280;
) and collagenase inhibitor (----).
of DEAE-Sepharose pre-equilibrated with this buffer. The column was eluted with a large volume of sodium barbitone buffer, and Fig. 3 illustrates the elution profile that was obtained. The tissue inhibitor was retarded by the column under these conditions, but not bound, and the fractions containing inhibitor were relatively free of contaminating protein, as determined by the A280 elution profile. The adsorbed protein was removed with 1 M-NaCl. Those fractions containing inhibitory activity were combined.
Heparin-Sepharose chromatography
The combined fractions from DEAE-Sepharose chromatography were dialysed for 6 h against 25mM-sodium cacodylate buffer containing 0.05% Brij 35, 0.02% NaN3 and lOmM-CaCl2 and applied to a column of heparin-Sepharose equilibrated with this buffer. The column was eluted with this buffer, and then with a salt gradient to remove the adsorbed protein. The inhibitor was eluted from the column with 0.2-0.4M-NaCl, whereas most of the protein applied passed straight through the column (Fig. 4) . Zinc-chelate affnity chromatography
The heparin-Sepharose fractions containing inhibitor were combined, and were dialysed overnight against 25 mM-sodium borate buffer, pH 8.0, containing 0.15M-NaCl, 0.05% Brij 35 and 0.02% . Heparin-Sepharose chromatography of rabbit bone inhibitor ofcollagenase Pooled fractions (45 ml) from DEAE-Sepharose chromatography in 25 mM-sodium cacodylate buffer, pH 7.6, containing lOmM-CaCl2, 0.05% Brij 35 and 0.02% NaN3 were applied to a column (0.9 cm x 5.0 cm) of heparin-Sepharose and eluted with this buffer. Adsorbed protein was removed by washing the column with a linear salt gradient (0-0.7M-NaCl);
, A 280; -collagenase inhibitor; --, conductivity. Further protein was eluted from the column after washing with 1 M-NaCl (not shown).
washed, and eluted in a stepwise manner, as described in the legend to Fig. 5 , which illustrates the elution profile, and the inhibitor was eluted from the column at pH 6.5. These fractions were quickly pooled and concentrated by ultrafiltration with a PM 10 membrane and stored at 40 C. Samples were taken from each stage of the purification (labelled 1-6, Scheme 1) and assayed for inhibitory activity against rabbit bone collagenase and for protein content. The results of these assays are shown in Table 1 . The purified inhibitor had a final specific activity of 26000units/mg, and was purified more than 1300-fold when compared with the starting concentrated medium. Only 9% of the original activity was recovered by this procedure. The purified inhibitor in dilute solutions rapidly lost activity, and a decrease in specific activity occurred during the final purification step, from 41000 to 26000 units/mg. The zinc-chelate column did not necessarily cause this loss of activity, since when this step was replaced with a further Ultrogel AcA 44 column, larger losses of activity were observed. A further purification step was necessary after the and equilibrated with the above buffer. The column was eluted at 18 ml/h with the following buffers: (1) 25 mM-sodium cacodylate, pH 6.5; (2) 25 mMsodium cacodylate, pH6.5, containing 0.8M-NaCl; (3) 50mM-sodium acetate, pH4.7, containing 0.8M-NaCl. All buffers contained Brij 35 (0.05%), NaN3 (0.02%) and CaCl2(1 mM). The column eluate was monitored for protein (A280, ) and collagenase heparin-Sepharose column to remove small amounts of contaminating protein. No suitable method was found to prevent this loss of activity. It is likely that the potential specific activity is greater than 41000units/mg, and probably approaches the values reported for pig synovial collagenase by Cawston & Tyler (1979 
Purity ofthe inhibitor preparation
The fractions from each stage of the purification procedure were labelled with l251 and denatured and reduced with SDS and 2-mercaptoethanol before SDS/polyacrylamide-gel electrophoresis. Fig. 6 shows the proteins present in each fraction after staining (a) and radioautography (b) of the SDS/ polyacrylamide gel. Trace contaminants could be seen in the radioautograph in the final zinc-chelatecolumn fraction.
To assess further the purity of the final preparation of rabbit bone inhibitor, the dried gel was cut vertically and then into 0.5cm horizontal strips, and each slice counted for radioactivity in a Packard PGD autogamma counter. The results demonstrated that 95% of the radioactivity was associated with the major protein band.
Interaction of purified rabbit bone inhibitor and purified rabbit bone collagenase Increasing amounts of the purified inhibitor were added to a known amount of purified collagenase in the assay, and the percentage inhibition was calculated at each concentration of inhibitor. These results are shown in Fig. 7 . It is possible to calculate the amount of inhibitor that interacts with the collagenase to give exactly 100% inhibition. From the graph obtained and by using the information given in the legend to Fig. 7 , it was calculated that 1 
Specificity ofrabbit bone inhibitor
The purified inhibitor blocked the activities of rabbit bone collagenase, gelatinase and proteoglycanase, and of human leucocyte collagenase and gelatinase. It did not inhibit either thermolysin or bacterial collagenase, or the serine proteinases trypsin and plasmin. The inhibitor also blocked the activity of pig synovial collagenase.
Discussion
In the present paper we describe a purification procedure for the collagenase inhibitor synthesized by newborn-rabbit bones in tissue culture. Although large numbers of bones were cultured (total of 12 litres of culture medium), only a small amount of purified inhibitor protein (180,g) was isolated. A number of factors are responsible for this low yield, which include the relatively small amounts of inhibitor present in the culture medium during the first 4 days and the overall low recovery of inhibitor activity by the purification procedure (9%). The isolated inhibitor was 95% pure. Two steps proved to be of particular value in the purification procedure. The concanavalin A-Sepharose column gave a good purification and selectively bound carbohydrate-containing protein. The DEAESepharose column retarded the inhibitor under the conditions used.
The purified rabbit bone inhibitor was a potent inhibitor of collagenase. It was relatively heat-stable, resistant to low concentrations of trypsin, but destroyed by high concentrations of trypsin and also by reduction and alkylation. It inhibited the three rabbit bone metalloproteinases and human leucocyte collagenase and gelatinase, but neither bacterial collagenase nor thermolysin, nor the serine proteinases trypsin and plasmin. These properties are similar to those reported for inhibitors purified from tendon cultures (Vater et al., 1979) and humanskin-fibroblast culture medium (Welgus et al., 1979) , and partially purified from bovine aorta cultures and pig smooth-muscle-cell culture medium (Nolan et al., 1978) . It is not certain, however, if these inhibitors are similar proteins, because differences do exist in their properties and also in the way they interact with collagenase. No enzyme-inhibitor complex was reported for the human tendon inhibitor (Vater et al., 1979) , and although the human fibroblast inhibitor (Welgus et al., 1979) interacted with collagenase on a mol/mol basis, the binding appeared to be weak, since no complex of enzyme and inhibitor could be demonstrated. The rabbit bone inhibitor bound to purified collagenase with a 1: 1 stoichiometry. The inhibition was not reversible either by trypsin treatment or by addition of mercurials, as also found for the pig aorta inhibitor . The rabbit bone inhibitor binds tightly to the enzyme, and a complex is formed of higher molecular weight (T. E. Cawston, unpublished work). A detailed study of the interaction between purified enzyme and purified inhibitor will therefore be necessary to determine how the inhibitor interacts with the enzyme and the precise relationship of such an enzyme-inhibitor complex to the latent enzyme. The physiological role of the rabbit bone inhibitor of collagenase remains unclear. Because the inhibitor specifically blocks the activity of mammalian metalloproteinases other than collagenase, we have tentatively named the inhibitor 'TIMP' (Tissue Inhibitor of MetalloProteinases) so that it can be distinguished from other inhibitors that are not synthesized by tissues in culture. Much interest has focused on the amount of this inhibitor ('TIMP') relative to enzyme found in the culture media of connective tissue that is actively resorbing. Cambray et al. (1980) showed that amounts of inhibitor were lower in rabbit synovium cultures when the tissue was taken from experimentally arthritic rabbits, as compared with normal animals. Sellers et al. (1980) reported lower amounts of inhibitor and increased active collagenase activities in bone cultures where agents were added to induce resorption. Although it is not yet clear if the inhibitor isolated from rabbit bones reacts with collagenase to form the latent complex, it seems likely from these studies that the potent inhibitor of collagenase that we have purified plays a vital role in controlling the extracellular activity of metalloproteinases in vivo.
